Viewing Study NCT04544995


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2026-02-02 @ 5:51 AM
Study NCT ID: NCT04544995
Status: TERMINATED
Last Update Posted: 2025-07-16
First Post: 2020-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose escalation View
None Dose expansion View
None Dostarlimab View
None Niraparib View
None Osteosarcoma View
None Neuroblastoma View